Mobius Therapeutics
St Louis · Founded 2006
About Mobius Therapeutics
Mobius Therapeutics is an early-stage venture focused on ophthalmic surgery solutions. Its first product, Mitosol, is a system for delivering antifibrotic agents in glaucoma, refractive, and corneal surgery. It is awaiting regulatory approval, with additional product applications in earlier stages of development.
Company Facts
- Founded: 2006
- Legal name: Mobius Therapeutics LLC
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2013)
- Website: mobiustherapeutics.com
- Phone: 3144505933
Social Profiles
Canonical: https://fsome.com/organization/mobius-therapeutics-8343084 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.